Spravato (esketamine)
Coming soon!
We are getting close to adding Spravato, an FDA approved nasal spray of esketamine to our list of treatment options at Transformative. Spravato has been shown in multiple studies to effectively treat treatment-resistant depression and major depression with suicidality in conjunction with an antidepressant. Most major insurance plans cover this needed service.